In contrast to the results for MLL-AF9 and RUNX1-ETO9a-driven AML models, we observed earlier onset of cRAM cell-induced MDS/AML in Rag2−/− mice than WT mice (Fig. 5b), suggesting that cRAM cells are susceptible to adaptive immunity. This evidence concerns the gene RAG2 and acute myeloid leukemia.